Call Buying Activity Continues in BioCryst Pharma (BCRX), Targeting Upside in Shares Through July -Susquehanna

Susquehanna options strategist Alison Edwards notes call buying activity in BioCryst Pharma (NASDAQ: BCRX), as investors bought ~12k July 9 calls, adding to roughly 20K of the calls bought since early last week. A position of about 30k calls gives investors the right to buy ~3 mln shares if the shares nearly double current levels in mid-July.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Baldwin Insurance (BWIN) call put ratio 5.9 calls to 1 put with a focus on July 20 and 22.50 calls
• Visteon (VC) 354 contracts of June 120 calls as share price up 6%